Miromatrix Medical Inc.
MIRO · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 2,783.5% | -28.9% | -81.4% | – |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | 47.6% | -1,412.1% | -974.6% | 0% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,114.7% | -41,820.4% | -24,598.5% | -3,653.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,147.2% | -45,230% | -18,732.7% | -1,228.1% |
| EPS Diluted | -1.45 | -0.73 | -0.82 | -0.29 |
| % Growth | -98.6% | 11% | -182.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |